Medscape11d
Frequent Colorectal Polyp Diagnoses in Relatives Linked to Increased Risk for Colorectal Cancer
The risk for colorectal cancer was associated with the frequency of colorectal polyp diagnoses in relatives in a study based ...
Common cancer type could be detected with new blood test
A new blood test was found to detect colon cancer with more than 80% accuracy — and to rule it out for 90% of healthy people.
emjreviews.com3d
Family History of Frequent Polyps Linked to Increased Risk of Colorectal Cancer
Study reveals a higher frequency of polyp diagnoses in relatives increases the risk of colorectal cancer, especially ...
St. Luke's Hospital introduces AI technology to better find early signs of Colon Cancer
St. Luke's Hospital is using artificial intelligence (AI) technology that can help doctors find early signs of Colon Cancer.
Oxford BioDynamics’ EpiSwitch® CRC Blood Test Accurately Detects both Cancer and Polyps
Failed to fetch dynamically imported module: https://finance.yahoo.com/assets/_app/immutable/nodes/105.JzBkOQ-g.js ...
phillyvoice.com9d
A new blood test accurately screens for colorectal cancer, researchers say
Research that has not yet been peer-reviewed shows the newest blood test is more than 80% accurate in detecting colon cancer ...
8 facts about colon cancer that could save your life
While colon cancer has traditionally been associated with older adults, recent data reveals an alarming trend: cases are ...
Corridor Business3d
St. Luke’s Hospital is using AI technology for colon cancer detection
St. Luke’s Hospital in Cedar Rapids has announced that it is now offering patients enhanced colonoscopies with the GI Genius ...
Healio7d
‘Frequent polyp diagnoses’ in near relatives linked to higher colorectal cancer risk
People with first-degree relatives who were repeatedly diagnosed with colorectal polyps appeared at increased risk for ...
Oxford BioDynamics, Plc: Oxford BioDynamics' EpiSwitch CRC Blood Test Accurately Detects both Cancer and Polyps
Results of multi-institutional clinical study published in peer reviewed journal 'Cancers' confirms efficacy ofOxford BioDynamics' EpiSwitch blood-based Colorectal No-Stool Test (NST) High ...